Cultural stigmas against treatment may be reduced by providing information about mental health in a second language.

Published Date: 26 Apr 2023

By using interpretation and translation to present information to communities in their native language, public health outreach initiatives frequently aim to break down communication barriers. However, bilingual people from various cultural backgrounds.

Read Full News

Latest News

Micro- and Nanoplastics: A Multiorgan Health Threat

Once present in the body, microplastics and nanoplastics can disrupt biological barriers and contribute to diseases impacting the gastrointestinal system and beyond.

Deep Dive: Is Bariatric Surgery Over?

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Nasal Strips: Fancy Tape or Medical Miracle?

Nasal strips flood your feed and promise better sleep. Dr Labos investigates whether nasal strips are worth the hype — or just a very convincing placebo.

Parkinson’s Treatment: Are Dopamine Agonists Fading?

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits against behavioral side effects.

Does Liso-Cel Offer Long-Term Survival Benefits in R/R LBCL?

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or refractory LBCL in the TRANSCEND study.

Treat or Wait, New Data on Asymptomatic Kidney Stones

Actively treating asymptomatic kidney stones is associated with lower odds of later recurrence and the need for surgery.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Todays Updates

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Latest News

Once present in the body, microplastics and nanoplastics can disrupt biological barriers and contribute to diseases impacting the gastrointestinal system and beyond.

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Nasal strips flood your feed and promise better sleep. Dr Labos investigates whether nasal strips are worth the hype — or just a very convincing placebo.

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits against behavioral side effects.

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or refractory LBCL in the TRANSCEND study.

Actively treating asymptomatic kidney stones is associated with lower odds of later recurrence and the need for surgery.

News All Time

CGRP May Lower Weather-Related Migraine Risk

Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention.

Hyperbaric Oxygen Therapy Can Help in Refractory Colitis

Hyperbaric oxygen therapy is well tolerated in treatment-refractory ulcerative colitis and enhances clinical outcomes alongside improvement in bowel perfusion.

Ontario Docs to Screen Younger Patients for Colon Cancer

Ontario Health is poised to lower the colorectal cancer screening age to 45 years on July 1.

Primary Care Meets Artificial Intelligence

As AI continues to evolve, its integration into primary care is revolutionizing patient diagnosis, treatment, and management.

Canada Introduces Safe Social Media Act to Protect Children

Canada wants to make social media safer for children, but experts say key questions about how the law will actually work remain unanswered.

Do Involuntary Admissions Affect Clinicians’ Mental Health?

Researchers are examining how involuntary psychiatric admissions affect emergency clinicians, with findings expected to inform future support and training programs.

Heartburn Meds in Pregnancy Not Linked to Child GI Risk

Gastrointestinal reflux is common during pregnancy.

HSSIB Warns on Safety Gaps in Online Prescribing

NHS systems have failed to keep pace with the rapid growth of independent online prescribing, leaving clinicians without the information they need to prescribe safely, HSSIB warns.

The COVID Vaccine Study the CDC Doesn’t Want You to See

Higher-ups at the CDC blocked publication of a COVID vaccine effectiveness study, citing methodologic weaknesses. Now the study has been published for all to read.

Key Updates in Non-Small Cell Lung Cancer From ASCO 2026

Updates in NSCLC from ASCO 2026 include phase 3 results for selpercatinib, ivonescimab, and sac-TMT, plus emerging data for neladalkib in ALK+ disease and sunvozertinib in the frontline setting.

Family Docs Must Fight for Patients Beyond the Exam Room

AAFP President Sarah Nosal, MD, argues some of the greatest threats to patient health originate not in disease but in policy.

The Clinical Cost of Sunscreen Misinformation

We have to help patients understand that the known dangers of prolonged UV exposure is a much greater risk than unproven concerns.

Early Ultrasound Results May Predict Scar Pregnancy Outcomes

Among cases of cesarean scar ectopic pregnancies, about two thirds progress toward a live birth, but nearly half of the women require a hysterectomy around the time of delivery.

Who Better to Treat Menopause Than NPs?

Will nurse practitioners step into the demand for menopause education and management?

FAST-Forward Trial Confirms 1-Week Breast RT at 10 Years

After a decade of follow-up, a 1-week RT regimen remains noninferior to standard treatment for early breast cancer, with similar rates of recurrence and long-term adverse events.

Vibrating Ingestible Capsule Flags Anorexia Relapse Risk

A vibrating capsule identifies subtle deficits in gut-brain signaling that are associated with relapse 6 months after weight restoration in anorexia nervosa.

Recommended News For You

investigating radiation oncology applications of artificial general intelligence.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

What Role Should Genomic Classifier Testing Play in Prostate Cancer?

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

examining differences in the rates of breast reconstruction following mastectomies.

Recommended Articles For You

Essential Techniques in Hematology for Better Care 

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage 

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health 

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

2.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

3.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

4.

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

5.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

1.

Cutting-Edge Cancer Treatments: Innovations and Outcomes in Non-Hodgkin Lymphoma

2.

Essential Applications in Oncology in Daily Practice

3.

Comprehensive Concepts in Oncology in Clinical Decision-Making

4.

Exploring the Latest Advances in PTLD Cancer Treatment

5.

The Mystery of Carotid Body Tumors: The Facts You Need to Know

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

Should We Use DARA Up Front As First-Line Therapy in MM?

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

5.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot